Atlas Trials

Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of Tomivosertib Combined With Paclitaxel in Advanced Breast Cancer

Clinical trial NCT04261218 · COMPLETED

Trial details

NCT number
NCT04261218
Sponsor
Translational Research in Oncology
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2020-08-25
Primary completion
2022-07-04
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.